Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2016-08-10

Clinical Trial Update: Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists

View source ↗

Summary

Clinical trial update describing drug utilization and safety events in children treated with esomeprazole, other proton pump inhibitors, or H2-receptor antagoni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cimetidine (CIMETIDINE)
  • DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)
  • Esomeprazole (Esomeprazole)
  • Famotidine (famotidine)
  • Lansoprazole (Lansoprazole)
  • Nizatidine (nizatidine)
  • Omeprazole (Omeprazole)
  • Pantoprazole (pantoprazole)
  • Rabeprazole (rabeprazole)
  • Ranitidine (Ranitidine)

Snippet

Sponsor: AstraZeneca | Conditions: Hospitalized Cases of Angioneurotic Oedema, Pneumonia | Status: COMPLETED